Shop
Checkout
CONFERENCES
REPORTS
MEDIA
PROFESSIONAL
EDUCATIONAL


InsightPharma Reports

Therapies for Solid Tumors
Therapies for Solid Tumors
September 2012
Table of Contents | Tables and Figures


Alzheimer's Disease
Alzheimer's Disease
July 2012
Table of Contents | Tables and Figures
Cancer Vaccines Market Study
Cancer Vaccines Market Study
February 2012
Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations
Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations
February 2012
Table of Contents | Tables and Figures


New Trends in Preventive and Therapeutic Vaccines
New Trends in Preventive and Therapeutic Vaccines
October 2011
Table of Contents | Tables and Figures | Executive Summary


Cytokine-Based Therapies and Inhibitors:R&D Pipelines, Markets, and Strategic Issues
Cytokine-Based Therapies and Inhibitors:R&D Pipelines, Markets, and Strategic Issues
September 2011
Table of Contents | Tables and Figures | Executive Summary


Autoimmune Diseases: Pipelines for Crohn's Disease, Multiple Sclerosis and Rheumatoid Arthritis
Autoimmune Diseases: Pipelines for Crohn's Disease, Multiple Sclerosis and Rheumatoid Arthritis
July 2011
Table of Contents | Tables and Figures
The Antiviral Pipeline: HIV, HCV, and Influenza
The Antiviral Pipeline: HIV, HCV, and Influenza
November 2010
Table of Contents | Tables and Figures | Order


Diabetes Pipeline: Intense Activity to Meet Unmet Need
Diabetes Pipeline: Intense Activity to Meet Unmet Need
September 2010
Table of Contents | Tables and Figures


Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
December 2009
Table of Contents | Tables and Figures | Executive Summary


First 1 2 3 4 Last 
Affiliated Reports

Personalized Medicine Partnering Terms and Agreements
May 2013


Osteoporosis - Pipeline Review, H1 2013
February 2013


Competitor Analysis: Enzyme Replacement Therapies
January 2013


Competitor Analysis: VEGF Antibodies - Bevacizumab and Ranibizumab Biosimilars and Biosuperiors
November 2012


Competitor Analysis: Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors
November 2012


Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors
November 2012


Peripheral Vascular Devices Market to 2018
October 2012


Diagnostics Partnering Terms and Agreements
October 2012


Companion Diagnostics Partnering Terms and Agreements
October 2012


Consensus Outlook: Multiple Sclerosis
September 2012


First 1 2 Last 


ALL REPORTS

ALL REPORTS
SERIES